US FDA approves Cysview™ (hexaminolevulinate HCl) for detection of bladder cancer

被引：0

|

作者：

不详

机构：

来源：

FUTURE ONCOLOGY | 2010年 / 6卷 / 07期

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

收藏

页码：1070 / 1070

页数：1

相关论文

共 50 条

[1] US FDA approves Cysview™ (Hexaminolevulinate HCl) for detection of bladder cancer
不详
EXPERT REVIEW OF ANTICANCER THERAPY, 2010, 10 (07) : 995 - 995
[2] Hexaminolevulinate hydrochloride in the detection of nonmuscle invasive cancer of the bladder
Di Stasi, Savino M.
De Carlo, Francesco
Pagliarulo, Vincenzo
Masedu, Francesco
Verri, Cristian
Celestino, Francesco
Riedl, Claus
THERAPEUTIC ADVANCES IN UROLOGY, 2015, 7 (06) : 339 - 350
[3] FDA APPROVES MILNACIPRAN HCl FOR THE MANAGEMENT OF FIBROMYALGIA
Stoltzfoos, Lonnie
CNS SPECTRUMS, 2009, 14 (02) : 64 - 64
[4] FDA approves duloxetine HCl for the management of fibromyalgia
Stoltzfoos, Lonnie
CNS SPECTRUMS, 2008, 13 (07) : 552 - 552
[5] US FDA approves Provenge® for the treatment of advanced prostate cancer
不详
EXPERT REVIEW OF VACCINES, 2010, 9 (06) : 548 - 548
[6] US FDA approves Jevtana® injection for advanced prostate cancer
不详
FUTURE ONCOLOGY, 2010, 6 (08) : 1208 - 1208
[7] US FDA approves Provenge® for the treatment of advanced prostate cancer
不详
EXPERT REVIEW OF ANTICANCER THERAPY, 2010, 10 (06) : 793 - 793
[8] US FDA approves Jevtana® injection for advanced prostate cancer
不详
EXPERT REVIEW OF ANTICANCER THERAPY, 2010, 10 (08) : 1169 - 1169
[9] US FDA approves Provenge® for the treatment of advanced prostate cancer
不详
FUTURE ONCOLOGY, 2010, 6 (06) : 882 - 882
[10] Does hexaminolevulinate imaging improve the detection and treatment of bladder cancer?
Adrian PM van der Meijden
Nature Clinical Practice Urology, 2006, 3 (1): : 22 - 23

← 1 2 3 4 5 →